The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Addition of metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND): Results of a multicenter, randomized phase II trial.
 
Ethan B. Ludmir
Employment - Alaunos Therapeutics (I)
 
Alexander Dean Sherry
No Relationships to Disclose
 
Bryan M. Fellman
No Relationships to Disclose
 
Suyu Liu
No Relationships to Disclose
 
Tharakeswara Bathala
No Relationships to Disclose
 
Cara L. Haymaker
Stock and Other Ownership Interests - Briacell
Consulting or Advisory Role - Nanobiotix
Research Funding - Avenge Bio (Inst); BTG (Inst); Dragonfly Therapeutics (Inst); Iovance Biotherapeutics (Inst); Obsidian Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent Appl No. 62/977, 672 (Inst)
 
Marina N. Medina-Rosales
No Relationships to Disclose
 
Emma B. Holliday
Research Funding - Merck Serono
 
Grace L. Smith
Consulting or Advisory Role - AstraZeneca; AstraZeneca
Research Funding - Varian Medical Systems (I)
Other Relationship - Oncora Medical (I)
 
Michael Sangmin Lee
Consulting or Advisory Role - Bayer Health; Delcath Systems; G1 Therapeutics; Imvax; Pfizer
Research Funding - Arcus Biosciences (Inst); Boehringer Ingelheim (Inst); EpimAb BioTherapeutics (Inst); Erasca, Inc (Inst); Merck (Inst); Repare Therapeutics (Inst); TriSalus Life Sciences (Inst); Xilis (Inst)
 
Dan Zhao
Consulting or Advisory Role - Affinit-T
Research Funding - CARsgen Therapeutics (Inst); Mirati Therapeutics (Inst)
 
Brandon George Smaglo
Consulting or Advisory Role - Ipsen; Syros Pharmaceuticals
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Marker Therapeutics
(OPTIONAL) Uncompensated Relationships - Ipsen
 
Cullen M. Taniguchi
Consulting or Advisory Role - Phebra; Xerient
Patents, Royalties, Other Intellectual Property - Oral amifostine for radio protection of the intestinal tract; PHD inhibitors for radio protection of the GI Tract
 
Eugene Jon Koay
No Relationships to Disclose
 
Matthew H. G. Katz
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Alcresta Therapeutics; Nestle health science; Taiho Oncology
Travel, Accommodations, Expenses - Intuitive Surgical
 
Robert A. Wolff
Honoraria - Conveners; Emirates Oncology Society
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Prajnan Das
Honoraria - Bayer; Imedex; Physicans' Education Resource
 
Shubham Pant
Consulting or Advisory Role - AskGene Pharma; Boehringer Ingelheim; Ipsen; Janssen; Novartis; Zymeworks
Research Funding - 4D Pharma (Inst); Amal Therapeutics (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); bionte (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Immuneering (Inst); ImmunoMET (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Purple Biotech (Inst); Rgenix (Inst); Xencor (Inst); Zymeworks (Inst)
 
Albert C. Koong
Stock and Other Ownership Interests - Aravive
 
Chad Tang
Consulting or Advisory Role - Bayer; Diffusion Pharmaceuticals; Siemens Healthineers
Research Funding - Noxopharm
Patents, Royalties, Other Intellectual Property - I have a patent on the utilization of a monoclonal antibody and we license this for use. We receive royalties <$1000 per year on this license.
Other Relationship - Osler Institute; Wolters Kluwer